CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum

Show full item record



Permalink

http://hdl.handle.net/10138/310447

Citation

DDD Study , Konrad , E D H , Nardini , N , Kuismin , O , Kurki , M I , Pietiläinen , O & Palotie , A 2019 , ' CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum ' , Genetics In medicine , vol. 21 , no. 12 , pp. 2723-2733 . https://doi.org/10.1038/s41436-019-0585-z

Title: CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum
Author: DDD Study; Konrad, Enrico D. H.; Nardini, Niels; Kuismin, Outi; Kurki, Mitja I.; Pietiläinen, Olli; Palotie, Aarno
Contributor organization: Institute for Molecular Medicine Finland
Genomics of Neurological and Neuropsychiatric Disorders
University of Helsinki
Center for Population, Health and Society
Centre of Excellence in Complex Disease Genetics
Aarno Palotie / Principal Investigator
Date: 2019-12
Language: eng
Number of pages: 11
Belongs to series: Genetics In medicine
ISSN: 1098-3600
DOI: https://doi.org/10.1038/s41436-019-0585-z
URI: http://hdl.handle.net/10138/310447
Abstract: Purpose: Pathogenic variants in the chromatin organizer CTCF were previously reported in seven individuals with a neurodevelopmental disorder (NDD). Methods: Through international collaboration we collected data from 39 subjects with variants in CTCF. We performed transcriptome analysis on RNA from blood samples and utilized Drosophila melanogaster to investigate the impact of Ctcf dosage alteration on nervous system development and function. Results: The individuals in our cohort carried 2 deletions, 8 likely gene-disruptive, 2 splice-site, and 20 different missense variants, most of them de novo. Two cases were familial. The associated phenotype was of variable severity extending from mild developmental delay or normal IQ to severe intellectual disability. Feeding difficulties and behavioral abnormalities were common, and variable other findings including growth restriction and cardiac defects were observed. RNA-sequencing in five individuals identified 3828 deregulated genes enriched for known NDD genes and biological processes such as transcriptional regulation. Ctcf dosage alteration in Drosophila resulted in impaired gross neurological functioning and learning and memory deficits. Conclusion: We significantly broaden the mutational and clinical spectrum of CTCF-associated NDDs. Our data shed light onto the functional role of CTCF by identifying deregulated genes and show that Ctcf alterations result in nervous system defects in Drosophila.
Subject: CTCF
neurodevelopmental disorders
Drosophila melanogaster
intellectual disability
chromatin organization
DE-NOVO MUTATIONS
GENE ONTOLOGY
EXPRESSION
DROSOPHILA
HUMANS
INACTIVATION
DATABASE
LIBRARY
TOOL
1184 Genetics, developmental biology, physiology
Peer reviewed: Yes
Rights: cc_by_nc_sa
Usage restriction: openAccess
Self-archived version: publishedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
s41436_019_0585_z.pdf 1.999Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record